Now showing items 1-9 of 9
Bleeding risk in patients with acute coronary syndrome in a Turkish population results from the Turkish acute coronary syndrome registry (TACSER) study
Objective Bleeding is one of the most important causes of mortality in patients with acute coronary syndrome (ACS). This study therefore aimed to investigate bleeding risk in patients with ACS who were scheduled to receive ...
Can a patient with pulmonary hypertension travel safely by plane?
Air travel is known as the safest way of transportation. Therefore, patients with health problems prefer to travel by air; however, those with heart or lung issues, who do not have any problems under normal conditions, may ...
Nicorandil and contrast-induced nephropathy
(Sage Publications Inc, 2020)
Correction to: discordant serum lipid paramete
APOA5 -1131T>C polimorfiminin koroner arter hastalarında obezite ile ilişkisi
(Turkish Soc Cardiology, 2020)
Objective: Genetic risk factors that cause coronary artery disease (CAD) demonstrate variations in different populations. In this study, a single nucleotide polymorphism in the APOA5 gene was targeted to determine genetic ...
Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease
Coronary artery disease (CAD) is still the preliminary cause of mortality and morbidity in the developed world. Identification of novel predictive and therapeutic biomarkers is crucial for accurate diagnosis, prognosis and ...
Nutritional status and severity of coronary artery disease
Objective The aim of this study is to evaluate the association between Nutritional Risk Index (NRI), a simple tool to assess nutritional status, and coronary artery disease severity and complexity in patients ...
Is air travel safe for patients with cardiac implantable electronic devices?
Parallel to the rapid expansion of air travel services and advances in medical technology, more passengers with cardiac implantable electronic devices (CIEDs) fly each year. In general, commercial airline flights are ...
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: real-world experience from Turkey (ARNi-TR)
Objective: Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angio tensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ...